Abstract:Objective To investigate the effect of BCG-PSN by different methods of intervention on airway inflammation and airway reactivity in asthmatic mouse model. Methods Balb/c mice were sensitized by ovalbumin to establish the asthmatic mouse model and divided into normal group, asthma group and BCG-PSN intervention group.For BCG-PSN intervention group, the dose of BCG-PSN was 20 μg/60 μl, all of which were intervened after the final excitation, and according to the intervention methods, the intervention group was subdivided into the intramuscular injection group ( im) and intranasal administration after anesthesia group (in). Airway responsiveness was measured by Buxco company's mice overall volume scanning method in 2 d, 14 d respectively after final excitation, which was demonstrated by enhanced breathing intermittence (Enhanced Pause, Penh) under different concentrations of methacholine stimulation. Airway reactivity was evaluated by PC100 ( Mch excitation concentration when the increased airway reactivity is 2 times of physiological saline ( NS) ) and Penh/NS% comprehensively. The bronchoalveolar lavage fluid was collected and the ratio of eosinophils was counted in the smears stained with haematoxylin and eosin, and with pathological examination of lung tissue. Results BCG-PSN (im) group PC100 was (9.48±3.06) mg/ml in early stages, compared with asthma group (4.79±1.51)mg/ml, P＜0.05, in the later stages PC100 was (4.96±1.88) mg/ml, (5.55± 3.11) mg/ml for asthma group, there was no statistically significant differences in these two groups, for BCG-PSN(in) group, PC100 is (12.39±4.89)mg/ml,(9.19±2.35)mg/ml in early and later stages respectively, compared with the asthma group, had statistical significance (P＜0.05), and in later stages, BCG-PSN(in) group was significantly higher than BCG-PSN(im) group. For the Eos% in BALF, asthma group was (40.73± 6.01)%, and BCG-PSN(im) group was (35.65±4.27)%, there was no significant difference between these two groups, BCG-PSN(in) group was (30.98±5.45)%, which is significantly lower than the asthma group (P＜0.05). Conclusion BCG-PSN has a therapeutic effect on the asthmatic mice. The effects of BCG-PSN by intranasal administration after anesthesia are equivalent to or even superior to the effects by intramuscular administration, BCG-PSN by intratracheal administration is expected to become a new way for prevention and therapy on asthma.

Effects of Bacillus Calmette-Guerin on Th1/Th2 Balance of Peripheral Blood Mononuclear Cells in Patients with Atopic Asthma

Expression of IFN-γ,IL-4 and IL-17A in asthmatic mice vaccinated with BCG and HepB in neonatal period

Effect of Bacillus Calmette-Guerin Treatment on Airway Inflammation and T Regulatory Cells in Mice with Asthma

Effects of bacillus calmette-guerin polysaccharide nucleotide on CD4+ CD25+ Treg in lymph of asthmatic mouse model

Phosphodiesterases Inhibition by Bacilli Calmette-Guérin Contributes to Decrease Asthma in Allergic Rats

A comparative study on immune modulatory effects of bacilli Calmette-Guérin polysaccharides nucleic acid in asthma and chronic obstructive pulmonary disease

Effects of Bacillus Calmette-Guerin on airway inflammation, T helper cell differentiation and serum OVA-specific IgE levels in a mouse model of asthma

Effect of BCG DNA on IFN- Γand IL-4 Secreted by Peripheral Blood Mononuclear Cells in Asthma Patients

Study about effects of BCG treatment on expression of stem cell factor in asthmatic mice

Effects of bacillus Calmette -Guerin vaccinated at ovalbumin sensitization on airway inflammation in a mouse model of asthma

Effect of BCG Treatment on Airway Inflammation and T Regulatory Cell of Asthma Mouse

Effect of BCG-PSN Acupoint Injection on IgE Content and Asthma Control Test Score of Bronchial Asthma

The effect of bacillus Calmette-guerin vaccination and PPD on CD4~+ CD25~+ regulatory T cells and the lung pathology in a murine model of asthma

The Expression of Dendritic Cells and Effects of Bacillus Calmette-Guérin in Asthma Mice Model

Influence of Bacillus Calmette-Guerin on Expression of GATA-3 in Lung of Asthmatic Mouse

Effects of bacillus calmette-guerin polysaccharide nucleotide by different ways of intervention on airway inflammation and airway hyperresponsiveness in asthmatic mouse model

Effect of oral BCG on the treatment of allergic asthmain mouse model

[An Experimental Study of the Effect of Bacille Calmette-Guerin Vaccine on the Production of a Rat Asthmatic Model and Its Relation with Gamma Delta T Cells].

Mycobacterium Bovis-Bacillus Calmette-Guerin and Asthma.

Effect of Bacille Calmette-Guerin Polysaccharide Nucleic Acid (BCG-PSN) on the Expression of T Cell-Derived Cytokines in Patients with Atopic Dermatitis